AbbVie breaks ground for a new facility at its Rhineland-Palatinate site in Germany. (Image: AbbVie)
May 3, 2024 02:36 PM EDT
R&D
Pharma

Ab­b­Vie puts $161M in­to new R&D site in Ger­many, will add 300 jobs

Katherine Lewin

News Reporter

Ab­b­Vie is in­vest­ing around €150 mil­lion ($161 mil­lion) in­to an R&D site at its Rhineland-Palati­nate lo­ca­tion in Ger­many which it ex­pects to com­plete in 2027 …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Bridge­Bio shares promis­ing re­sults in tri­al of Cana­van dis­ease gene ther­a­py

CRISPR ther­a­py re­duces swelling at­tacks by 81% in In­tel­lia fol­low-up study

Fac­ing lost re­bates, MGM Re­sorts to stop cov­er­ing GLP-1 weight loss shots

Ex­clu­sive: Uni­ver­si­ty of Toron­to spin­out rais­es $53.5M to cre­ate new obe­si­ty drugs with AI

Icon's quar­ter­ly earn­ings hit by biotech and phar­ma pull­back

sponsored

IDEAYA Bio­sciences: Tar­get­ing un­met mar­ket needs with pre­ci­sion on­col­o­gy

A service from the Financial Times